Vasamed OTC Stock Buy Hold or Sell Recommendation

VSMD -  USA Stock  

USD 0.001  0.0018  64.29%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Vasamed is 'Strong Sell'. Macroaxis provides Vasamed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Vasamed positions. The advice algorithm takes into account all of Vasamed's available fundamental, technical, and predictive indicators you will find on this site.

Vasamed Advice 

 
Refresh
The advice is provided from Vasamed's buy-and-hold perspective. Also, please take a look at Vasamed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Vasamed and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Vasamed.

Execute Vasamed Buy or Sell Advice

The Vasamed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Vasamed. Macroaxis does not own or have any residual interests in Vasamed or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Vasamed's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell VasamedBuy Vasamed
Strong Sell

Volatility

Out of controlDetails

Hype Condition

Under hypedDetails

Current Valuation

Fairly ValuedDetails

Odds of Distress

Significantly HighDetails

Economic Sensitivity

Moves completely opposite to the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Vasamed has a Mean Deviation of 16.97, Semi Deviation of 18.2, Standard Deviation of 56.35, Variance of 3175.81, Downside Variance of 4158.99 and Semi Variance of 331.2
We provide advice to complement the current expert consensus on Vasamed. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Vasamed is not overpriced, please validate all Vasamed fundamentals, including its cash per share and the relationship between the cash flow from operations and current asset . As Vasamed appears to be a penny stock we also recommend to double-check its price to sales numbers.

Vasamed Trading Alerts and Improvement Suggestions

Vasamed generated a negative expected return over the last 90 days
Vasamed has high historical volatility and very poor performance
Vasamed has some characteristics of a very speculative penny stock
Vasamed has a very high chance of going through financial distress in the upcoming years
The company currently holds 2.17 M in liabilities. Vasamed has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations when due.
The entity reported the previous year's revenue of 3.43 M. Net Loss for the year was (1.93 M) with profit before overhead, payroll, taxes, and interest of 1.73 M.
Vasamed currently holds about 136.82 K in cash with (785.7 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Vasamed Returns Distribution Density

The distribution of Vasamed's historical returns is an attempt to chart the future uncertainty of Vasamed's future price movements. The chart of the probability distribution of Vasamed stock daily returns describes the distribution of returns around its average expected value. We use Vasamed price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Vasamed returns is essential to provide solid investment advice for Vasamed stock.
Mean Return4.13Value At Risk-64.29
Potential Upside0.16Standard Deviation50.05
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Vasamed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Vasamed Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Vasamed or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Vasamed stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Vasamed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
4.28
β
Beta against DOW-3.86
σ
Overall volatility
25.75
Ir
Information ratio 0.07

Vasamed Volatility Alert

Vasamed is showing large volatility of returns over the selected time horizon. We encourage all investors to investigate this asset further to make sure related market timing strategies are aligned with all the expectations about Vasamed implied risk. Vasamed is a penny stock. Even though Vasamed may be a good instrument to invest, many penny otc stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside scenarios of investing in Vasamed or similar risky assets. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Vasamed instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Vasamed Fundamentals Vs Peers

Comparing Vasamed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Vasamed's direct or indirect competition across all of the common fundamentals between Vasamed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Vasamed or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Vasamed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Vasamed by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Vasamed to competition
FundamentalsVasamedPeer Average
Return On Equity(367.00) %(0.31) %
Return On Asset(74.10) %(0.14) %
Profit Margin(56.17) %(1.27) %
Operating Margin(47.24) %(5.51) %
Current Valuation16.75 M16.62 B
Shares Owned by Institutions0.31 %39.21 %
Price to Earning(0.33) X28.72 X
Price to Sales0.84 X11.42 X
Revenue3.43 M9.43 B
Gross Profit1.73 M27.38 B
EBITDA(1.47 M)3.9 B
Net Income(1.93 M)570.98 M
Cash and Equivalents136.82 K2.7 B
Cash per Share0.02 X5.01 X
Total Debt2.17 M5.32 B
Current Ratio0.33 X2.16 X
Book Value Per Share(2.10) X1.93 K
Cash Flow from Operations(785.7 K)971.22 M
Earnings Per Share(0.24) X3.12 X
Number of Employees1018.84 K
Beta0.96-0.15
Market Capitalization2.89 M19.03 B
Total Asset3.08 M29.47 B
Retained Earnings(96.99 M)9.33 B
Working Capital143 K1.48 B
Current Asset1.69 M9.34 B
Current Liabilities1.55 M7.9 B
Z Score-41.88.72

About Vasamed Buy or Sell Advice

When is the right time to buy or sell Vasamed? Buying financial instruments such as Vasamed OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Vasamed investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Vasamed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Disruptive Technologies Thematic Idea Now

Disruptive Technologies
Disruptive Technologies Theme
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. Disruptive Technologies theme has 53 constituents.
View All  Next Launch Disruptive Technologies
Also, please take a look at Vasamed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Vasamed information on this page should be used as a complementary analysis to other Vasamed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Vasamed OTC Stock analysis

When running Vasamed price analysis, check to measure Vasamed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vasamed is operating at the current time. Most of Vasamed's value examination focuses on studying past and present price action to predict the probability of Vasamed's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vasamed's price. Additionally, you may evaluate how the addition of Vasamed to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
The market value of Vasamed is measured differently than its book value, which is the value of Vasamed that is recorded on the company's balance sheet. Investors also form their own opinion of Vasamed's value that differs from its market value or its book value, called intrinsic value, which is Vasamed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vasamed's market value can be influenced by many factors that don't directly affect Vasamed underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vasamed's value and its price as these two are different measures arrived at by different means. Investors typically determine Vasamed value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vasamed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.